LEADER 03880nam  22006255  450 
001 9910298283003321
005 20200630100330.0
010   $a94-017-9469-3
024 7 $a10.1007/978-94-017-9469-5
035   $a(CKB)3710000000269479
035   $a(EBL)1966772
035   $a(SSID)ssj0001372134
035   $a(PQKBManifestationID)11898722
035   $a(PQKBTitleCode)TC0001372134
035   $a(PQKBWorkID)11302218
035   $a(PQKB)11660006
035   $a(DE-He213)978-94-017-9469-5
035   $a(MiAaPQ)EBC1966772
035   $a(PPN)182094537
035   $a(EXLCZ)993710000000269479
100   $a20141028d2015      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aDan Shen (Salvia miltiorrhiza) in Medicine $eVolume 1. Biology and Chemistry /$fedited by Xijun Yan
205   $a1st ed. 2015.
210  1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2015.
215   $a1 online resource (234 p.)
300   $aDescription based upon print version of record.
311   $a94-017-9468-5 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aMateria Medica and Plant Resource -- Distribution and Habitat of Danshen -- Biological Characters of Danshen -- A Study on the Cultivation of Danshen -- Danshen?s in vitro Culture -- Genetics and Breeding of Danshen -- Water Soluble Components of Danshen -- Liposoluble chemical constituents in Danshen.
330   $aThis book reviews research on Dan Shen, compiles data from clinical trials and biological experiments, and summarizes the latest research advances. It covers the medicinal herb, herbal pieces, and new proprietary drugs that contain it; it also covers simple and compound, traditional and contemporary formulas, and addresses a broad range of subjects, including: standardized cultivation;  biodiversity; effective substances and their biological activities; quality control; and clinical trials. The book goes on to present the clinical trials on Dantonic, especially focusing on its therapeutic effects for coronary heart disease. It discusses compound prescriptions and compatibilities, from the herbal piece level to composition level, and describes approaches to research on modern Chinese medicine.   Volume 1 describes the biology and chemistry of Dan Shen, while Volume 2 focuses on pharmacology and quality control. Volume 3 describes the clinical research on Dan Shen.   Editor Xijun Yan is the President of Tianjin Tasly Group and a Member of the TCM Standardization Technical Committee. Gathering contributions from more than 100 authors working in the field of pharmaceutical and clinical research, the book presents and analyzes the available information from multiple aspects, reflects the current status of Dan Shen research, and offers an essential reference work for further research and development.
606   $aPharmacology
606   $aAlternative medicine
606   $aCardiology
606   $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007
606   $aComplementary & Alternative Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H17007
606   $aCardiology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33037
615  0$aPharmacology.
615  0$aAlternative medicine.
615  0$aCardiology.
615 14$aPharmacology/Toxicology.
615 24$aComplementary & Alternative Medicine.
615 24$aCardiology.
676   $a610
676   $a615
676   $a616.12
702   $aYan$b Xijun$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910298283003321
996   $aDan Shen (Salvia miltiorrhiza) in Medicine$92498355
997   $aUNINA